James R. Bylund
Chief Operating OfficerMr. James R. Bylund, also known as Jim, served as Senior Vice President of Global Operations and Information Technology at Repligen Corporation since March 2020 until January 1, 2022 and serves as Chief Operating Officer since January 1, 2022. He joined Repligen Corporation in March 2020. Prior to Repligen, Mr. Bylund worked at Thermo Fisher Scientific in a number of roles including Vice President and General Manager of the Single Use Technologies Business Unit and Vice President of Global Operations for the Bioproduction Division. He served as Executive Vice President of Data & Clinical Operations at Verisk Health, Inc. Mr. Bylund has a wealth of leadership experience across multiple industries. He began his career at Eli Lilly and Company, where he served in a variety of cross-functional leadership roles. He was the Chief Operating Officer within the Insurance Solutions division of Fiserv, Inc. and he was responsible for global operations for the bioprocess production business of Thermo Fisher Scientific Inc. Mr. Bylund received a B.S in Accounting from Utah State University and a Masters Degree in Business Administration from Indiana University.
Positions
- Company NameRepligen CorporationStock CodeRGENPositionChief Operating OfficerColleagues
- OLOlivier LoeillotPresident, CEO & Director
- MDMartin D. MadausIndependent Chair of the Board
- JKJason K. GarlandCFO & Chief Compliance Officer
- AJAnthony J. HuntAdvisor
- RKRalf KuriyelSenior Vice President of Research & Development
- GPGlenn P. MuirIndependent Director
- MAMargaret A. PaxIndependent Director
- NMNicholas M. BarthelemyIndependent Director
